Biological resources such as plant parts are regularly used in the research of pharmaceuticals, food, nutraceuticals, pest control, bioremediation, etc. Cosmetics, chemicals and luxury product companies are focusing heavily on ingredients derived from biological materials. Innovators use biological resources from India but are still not much familiar with the Biological Diversity Act, 2002, a law that governs utilization of biological resources from India and access benefit sharing. Hence due to the lack of awareness, researchers or companies can be found liable for breach of this law unintentionally. Keeping that in mind, IIPRD and Khurana and Khurana (K&K) have put together a session to demystify various provisions under the Biological Diversity Act and approvals required from the National Biodiversity Authority (NBA), wherein the session will include below aspects:
Ms. Mita Shaikh Mita has over 26 years of experience in patent matters relating to technologies in the field of pharmaceuticals, biotechnology, and chemicals. Mita has been actively involved in Client Counselling, preparing patent specification, attending to prosecution and opposition matters at the Indian IPO, assisting clients in strategy for securing patent rights globally, rendering various patent infringement and other opinions. Mita has been clients about various approvals required under the Biological Diversity Act, 2002 and assisted in making applications to the National Biodiversity Authority (NBA). She has also represented clients at various personal and committee Hearings at the NBA. Mita holds B.Sc. in Chemistry from Mumbai University, B.Sc. in Botany from Mumbai University, and Masters in Plant Physiology from Mumbai University. She is a certified patent agent with Indian Patent Office and also holds PG diploma in patents law from NALSAR University of Law, Hyderabad.